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Abstract
The recognition of hydrogen sulfide (H2S) as an endogenously produced gas with signaling potential has
stimulated research on a multitude of physiological effects mediated in the cardiovascular, immune, gastroin-
testinal, genitourinary, endocrine, and central nervous systems. The heightened activity in the area of H2S
biology led to convening of the first international conference on H2S in Shanghai in the summer of 2009 and to
two Forum issues published in 2010 by Antioxidants & Redox Signaling on the physiological effects of H2S. Yet,
fundamental questions regarding the biogenesis and regulation of H2S, the bioenergetics of its catabolism, its
tissue concentrations, and elucidation of its molecular targets remain. Some of these issues are the subject of the
current Forum on H2S. Antioxid. Redox Signal. 15, 339–341.
Reactions in the sulfur metabolic pathway involvingthe amino acids cysteine and homocysteine are potential
sources of hydrogen sulfide (H2S) (4, 28). These include the
two enzymes in the transsulfuration pathway, cystathionine
b-synthase (CBS), and c-cystathionase (CSE), which succes-
sively convert serine and homocysteine to cystathionine and
cystathionine, to cysteine. Lax substrate specificity creates the
potential for a multitude of alternative reactions to be cata-
lyzed by both enzymes leading to H2S generation from either
cysteine or homocysteine or both (6, 7, 27). A third potential
route for H2S generation is via the combined actions of cys-
teine aminotransferase and mercaptopyruvate sulfur-
transferase (26), enzymes involved in cysteine catabolism.
However, the product of coupling these two enzymes is
persulfide rather than H2S, which can be liberated in the
presence of reductant (15).
An efficient mitochondrial pathway for H2S oxidation ex-
ists (10) and is important for holding steady-state tissue levels
of H2S at very low values. This has led to the hypothesis that
H2S might function as an oxygen sensor since, under condi-
tions of hypoxia, the catabolic removal of H2S would be im-
peded, leading to augmented H2S levels and activation of its
signaling responses (23). Similarities between the effects of
H2S and hypoxia and enhancement and abrogation of the
hypoxic responses by H2S precursors and H2S synthesis in-
hibitors, respectively, support the proposal that H2S might be
involved in oxygen sensing (23).
The discovery ofH2S as a physiological mediatorwasmade
by Abe and Kimura, who first reported its neuormodulatory
effects (1) and soon thereafter, its vasorelaxant effect on
smooth muscle (11). Today, a plethora of physiological effects
are associated with H2S with some of the major links being to
the cardiovascular and central nervous systems and to in-
flammation. H2S modulates a range of cardiovascular effects,
including cardioprotection against ischemic and myocardial
reperfusion injury and vascular contraction or relaxation (9,
23, 25, 29). The endothelial-derived relaxing factor activity of
H2S in mice lacking the CSE gene is controversial, with two
groups reporting conflicting results. Thus, Wang and co-
workers reported marked age-dependent hypertension (30),
whereas Ishii and coworkers reported a normotensive phe-
notype in the CSE knockout mice (14). H2S stimulates
opening of KATP channels, suggesting a mechanism for its
vasorelaxant effects in addition to its reported involvement in
the Nrf2 and ERK and PI3K/Akt signaling pathways (5, 13,
31). In brain, H2S has varied effects ranging from enhancing
hippocampal long-term potentiation (1), to triggering calcium
waves and increasing intracellular calcium levels in astrocytes
(22), to increased neuroprotection by stimulating glutathione
synthesis (19, 20). A possible mechanism for neuromodulation
by H2S involves induction of cyclic AMP synthesis and acti-
vating N-methyl D-aspartate-receptor-mediated excitatory
postsynaptic currents (18). Both pro- and anti-inflammatory
effects have been ascribed to H2S and efforts are underway to
develop the therapeutic potential of H2S-releasing drugs to
counter inflammatory diseases.
Large discrepancies have been reported in the literature on
tissue concentrations of H2S and H2S production rates in the
presence of exogenous substrate. These stem in part from the
technical difficulties associated with handling H2S, which is
redox sensitive, and the considerably larger tissue stores of
sulfane sulfur and acid-labile sulfur that can be released if
adequate precautions are not taken during sample prepara-
tion. Additionally, the complexity in utilization of cysteine
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and/or homocysteine for H2S generation by CBS and CSE
leads to a significant underestimation of H2S production rates
and bias against CBS when only cysteine is applied as sub-
strate, which is commonly the case in the field. Finally, the use
of compounds such as hydroxylamine and aminooxyacetate
that inhibit many pyridoxal phosphate enzymes and are not
specific for CBS or CSE produces results that are not readily
interpretable. Two articles in this Forum address these
quantitative issues surrounding H2S determination. In one,
Levitt and coworkers report that steady-state tissue levels of
H2S are negligibly low with the exception of aorta, which
exhibits 20–100 times higher H2S concentrations (21). In the
other article, the author’s group uses quantitative Western
blot analyses to determine the absolute protein levels of CBS
and CSE in liver and kidney and reports the tissue H2S pro-
duction capacity in the presence of saturating concentrations
of cysteine and homocysteine used alone or in combination as
substrates (16). These studies reveal the differential impor-
tance of CBS versus CSE in various tissues. From simulations
of the liver data adjusted for the difference in protein levels of
CBS and CSE, it is estimated that CSE accounts for *96%
of H2S production at physiologically relevant concentrations
of substrate.
Bouillaud and coworkers discuss sulfide bioenergetics in
the context of the mitochondrial catabolic pathway and the
similarities between cyanide and H2S inhibition of cyto-
chrome c oxidase (3). They also discuss potential mechanisms
for neutralizing sulfide particularly as it pertains to the
biology of colonocytes, cells that are routinely exposed to
high sulfide concentrations, and to the invertebrates living in
sulfide-rich habitats. The first enzyme in the H2S oxidation
pathway, sulfide quinone reductase, has a very high affinity
for sulfide, and oxidation activity can be detected at intra-
cellular sulfide concentrations ‡ 10–20 nM, thus protecting
cytochrome c oxidase from inhibition. These data also argue
against significant steady-state H2S levels in tissues under
normoxic conditions. However, when oxygen concentrations
are limiting, H2S levels are expected to rise leading to inhi-
bition of cytochrome c oxidase concomitant with enhanced
mitochondrial reactive oxygen species generation, which is in
fact observed under hypoxic conditions.
Tiranti and coworkers discuss the effects of chronic sulfide
exposure as seen in the inherited disorder, ethylmalonic en-
cephalophathy, on degradation of cytochrome c oxidase (8).
Ethylmalonic encephalopathy results from mutations in
Ethe1, the gene encoding the second enzyme in the mito-
chondrial sulfide oxidation pathway, sulfur dioxygenase.
Using tissue-specific conditional Ethe1 knockouts, the authors
demonstrate that the cytochrome c oxidase deficiency is lim-
ited to the tissues targeted for ablation. Hence, H2S acts locally
in tissue with disrupted Ethe1, leading to heme a inhibition and
enhanced degradation of cytochrome c oxidase subunits.
Lo´pez-Garriga and co-workers (24) discuss hemeproteins
such as cyctochrome c oxidase, myoglobin, and hemoglobin
as targets for H2S. Inhibition of cytochrome c oxidase is re-
sponsible for decreasing metabolic activity and inducing a
hibernation-like state (2). The basis for the differential reac-
tivity of H2S with hemeproteins that results in formation of
stable hexacoordinate low spin FeIII-SH2 complex versus iron
reduction and conversion to an unligated FeII heme and the
influence of the iron oxidation state are discussed.
The remaining two articles focus on the neurophysiological
effects of H2S. One, a comprehensive review by Jin-Song
and colleagues (12), covers the current state of our under-
standing of the neurophysiology and neuropathology of H2S,
discussing the underlying cellular mechanisms and the neu-
roprotective effects of this gaseous mediator. The original
research article by Ichinose and coworkers examines the
protective effects of H2S on a murine model of Parkinson’s
disease induced by the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (17). They demonstrate that the neuro-
protective effects of H2S are correlated with induction of
antioxidant genes, including glutamate cysteine ligase and
heme oxygenase-1.
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